Mechanism of Action of Compound-13: An α1-Selective Small Molecule Activator of AMPK
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
AMPK is a sensor of cellular energy status and a promising target for drugs aimed at metabolic disorders. We have studied the selectivity and mechanism of a recently described activator, C2, and its cell-permeable prodrug, C13. C2 was a potent allosteric activator of α1-complexes that, like AMP, also protected against Thr172 dephosphorylation. Compared with AMP, C2 caused only partial allosteric activation of α2-complexes and failed to protect them against dephosphorylation. We show that both effects could be fully restored by exchanging part of the linker between the autoinhibitory and C-terminal domains in α2, containing the equivalent region from α1 thought to interact with AMP bound in site 3 of the γ subunit. Consistent with our results in cell-free assays, C13 potently inhibited lipid synthesis in hepatocytes from wild-type and was largely ineffective in AMPK-knockout hepatocytes; its effects were more severely affected by knockout of α1 than of α2, β1, or β2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 4×
“, 2014a) is also observed in vivo (Ducommun et al., 2014; Foretz et al., 2010; Timmermans et al., 2014).”
BackgroundMethodInfluentialSelf-citationStructure of mammalian AMPK and its regulation by ADP
Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., et al. (2011) · Nature · doi:10.1038/nature09932 · Cited by 926 · cited 14×
“The likely explanation for this anomaly came when it was suggested (Chen et al., 2013; Xin et al., 2013) that the original assignment of amino acid sequence to electron density in the a hook region (Xiao et al., 2011) may have been incorrect.”
BackgroundInfluentialFullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Self-citationStructural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591 · cited 1×
“The g subunits contain four tandem cystathionine b-synthase (CBS) repeats that provide four potential sites for adenine nucleotide binding, although only three are used (Xiao et al., 2007).”
BackgroundJørgensen, S. B., Viollet, B., Andreelli, F., Frøsig, C., Birk, J. B., Schjerling, P., Vaulont, S., Richter, E. A., & Wojtaszewski, J. F. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306205200 · Cited by 553 · cited 1×
“AMPKa1 / , AMPKa2 / and liver AMPK-null (AMPKa1 / and liver-specific AMPKa2 / ) mice were generated and bred, as previously described (Foretz et al., 2010; Jørgensen et al., 2004; Viollet et al., 2003).”
MethodSelf-citationGowans, G. J., Hawley, S. A., Ross, F. A., & Hardie, D. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.019 · Cited by 531 · cited 5×
“In addition to allosterically activating AMPK (a key part of the overall activationmechanism;Gowans et al., 2013), AMPbinding also promotes an increase in Thr172 phosphorylation, mainly by protecting the complex against dephosphorylation by protein phosphatases.”
BackgroundInfluentialSelf-citationThe AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499 · cited 1×
“AMPKa1 / , AMPKa2 / and liver AMPK-null (AMPKa1 / and liver-specific AMPKa2 / ) mice were generated and bred, as previously described (Foretz et al., 2010; Jørgensen et al., 2004; Viollet et al., 2003).”
MethodSelf-citationEmerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic
Sakamoto, K., & Holman, G. D. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90331.2008 · Cited by 481 · cited 3×
“Moreover, numerous studies have demonstrated that the activation of AMPK leads to increased fatty acid oxidation through phosphorylation of ors acetyl-CoA carboxylase-2 (ACC2) (Merrill et al., 1997) and glucose uptake in skeletal muscle involving phosphorylation of TBC1D1 (O’Neill et al., 2011; Pehmøller et al., 2009;…”
BackgroundSelf-citationO'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406
Self-citationSanders, M. J., Ali, Z. S., Hegarty, B. D., Heath, R., Snowden, M. A., & Carling, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706543200 · Cited by 347 · cited 6×
“Chem mutation in the g2 subunit (R531G), which renders AMPK complexes insensitive to AMP (Sanders et al., 2007), whereas activation by C2 was unaffected on AMPK containing a carbohydrate-binding-domain (CBD)-deletion mutant in the b1 subunit (b1 D1–185, which renders AMPK complexes insensitive to…”
BackgroundInfluentialHudson, E. R., Pan, D. A., James, J., Lucocq, J. M., Hawley, S. A., Green, K. A., Baba, O., Terashima, T., & Hardie, D. G. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00249-5 · Cited by 332
Self-citationSakamoto, K., Göransson, O., Hardie, D. G., & Alessi, D. R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2004 · Cited by 299 · cited 1×
“The major upstream kinase phosphorylating Thr172 in most mammalian cells is a complex containing the tumor suppressor kinase LKB1, which appears to be constitutively active (Alessi et al., 2006; Sakamoto et al., 2004).”
BackgroundAMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Dzamko, N., van Denderen, B. J. W., Hevener, A. L., Jørgensen, S. B., Honeyman, J., Galic, S., Chen, Z.-P., Watt, M. J., Campbell, D. J., Steinberg, G. R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056762 · Cited by 175 · cited 3×
“As previously described (Dzamko et al., 2010), b1 is the predominant isoform in mouse liver, and its deletion resulted in instability and/or degradation of the a subunits, thus reducing Thr172 reassigned sequence (also known as a-RIM2) shaded in orange.”
BackgroundMethodSelf-citationPehmøller, C., Treebak, J. T., Birk, J. B., Chen, S., MacKintosh, C., Hardie, D. G., Richter, E. A., & Wojtaszewski, J. F. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00115.2009 · Cited by 171 · cited 3×
“Moreover, numerous studies have demonstrated that the activation of AMPK leads to increased fatty acid oxidation through phosphorylation of ors acetyl-CoA carboxylase-2 (ACC2) (Merrill et al., 1997) and glucose uptake in skeletal muscle involving phosphorylation of TBC1D1 (O’Neill et al., 2011; Pehmøller et al., 2009;…”
BackgroundSelf-citationSteinberg, G. R., O'Neill, H. M., Dzamko, N. L., Galic, S., Naim, T., Koopman, R., Jørgensen, S. B., Honeyman, J., Hewitt, K., Chen, Z.-P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102434 · Cited by 164 · cited 2×
“Xiao et al. (2011) previously argued that site 1 was the important binding site for allosteric activation by AMP,whereasChen et al.”
BackgroundMethodSelf-citationHunter, R. W., Treebak, J. T., Wojtaszewski, J. F. P., & Sakamoto, K. (2011) · Diabetes · doi:10.2337/db10-1148 · Cited by 151 · cited 1×
“AMPK activity in cell extracts was determined by immunoprecipitationwith AMPKa1 or AMPKa2 antibodies from 50 mgmaterial, as previously described (Hunter et al., 2011).”
MethodSelf-citation
Cited by
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Garcia, D., & Shaw, R. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.032 · Cited by 1,978
AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.013 · Cited by 859
Self-citationAMPK activators: mechanisms of action and physiological activities
Kim, J., Yang, G., Kim, Y., Kim, J., & Ha, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.16 · Cited by 817
AMP-activated protein kinase: the current landscape for drug development
Steinberg, G. R., & Carling, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0019-2 · Cited by 754
Self-citationAMPK—Sensing Energy while Talking to Other Signaling Pathways
Hardie, D. G. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.013 · Cited by 583
Self-citation
Metadata
- Authors
- Hunter, R. W., Foretz, M., Bultot, L., Fullerton, M. D., Deak, M., Ross, F. A., Hawley, S. A., Shpiro, N., Viollet, B., Barron, D., Kemp, B. E., Steinberg, G. R., Hardie, D. G., & Sakamoto, K.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 21
- Issue
- 7
- Pages
- 866-879
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1965927487
- Cited by
- 123
- References
- 17
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.